{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:25:15Z","timestamp":1788236715798,"version":"build-2803163510"},"reference-count":110,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ygyno.2017.05.010","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T09:32:34Z","timestamp":1495099954000},"page":"416-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Indications for and complications of transfusion and the management of gynecologic malignancies"],"prefix":"10.1016","volume":"146","author":[{"given":"Paulina","family":"Cybulska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Tew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-9953","authenticated-orcid":false,"given":"Rekha","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.05.010_bb0005","author":"WHO"},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0010","article-title":"Tranfusions and their costs: managing patients needs and hospitals economics","volume":"9","author":"DR","year":"2005","journal-title":"Internet J. Emerg. Intens. Care Med."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2014.11.009","article-title":"Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database","volume":"136","author":"Prescott","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2017.05.010_bb0020","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/trf.13676","article-title":"Trends in United States blood collection and transfusion: results from the 2013 AABB blood collection, utilization, and patient blood management survey","volume":"56","author":"Whitaker","year":"2016","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/107327481502200106","article-title":"Transfusion indications for patients with cancer","volume":"22","author":"Watkins","year":"2015","journal-title":"Cancer Control"},{"key":"10.1016\/j.ygyno.2017.05.010_bb0030","first-page":"111","article-title":"Mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion","volume":"17","author":"Carson","year":"2002","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ygyno.2017.05.010_bb0035","series-title":"Hematology American Society of Hematology Education Program. 2010","first-page":"351","article-title":"Parenteral iron therapy in cancer-associated anemia","author":"Henry","year":"2010"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2017.05.010_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000083128","article-title":"Cancer-related anemia: pathogenesis, prevalence and treatment","volume":"68","author":"Birgeg\u00e5rd","year":"2005","journal-title":"Oncology"},{"issue":"15","key":"10.1016\/j.ygyno.2017.05.010_bb0045","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"Ludwig","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2017.05.010_bb0050","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer - a systematic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.05.010_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjmed.2003.12.008","article-title":"Prevalence and outcomes of anemia in cancer: a systematic review of the literature","volume":"116","author":"Knight","year":"2004","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2014.09.023","article-title":"Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated?","volume":"91","author":"Bishop","year":"2015","journal-title":"Int. J. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0065","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0360-3016(03)00123-8","article-title":"Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis","volume":"56","author":"Dunst","year":"2003","journal-title":"Int. J. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0360-3016(89)90007-2","article-title":"Prognostic value of hemoglobin concentrations and blood-transfusions in advanced-carcinoma of the cervix treated by radiation-therapy - results of a retrospective study of 386 patients","volume":"16","author":"Girinski","year":"1989","journal-title":"Int. J. Radiat. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2017.05.010_bb0075","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E","article-title":"The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix","volume":"86","author":"Grogan","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.010_bb0080","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0360-3016(01)01523-1","article-title":"Tumor hypoxia, p53, and prognosis in cervical cancers","volume":"50","author":"Haensgen","year":"2001","journal-title":"Int. J. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.010_bb0085","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0360-3016(83)90060-3","article-title":"Pretreatment prognostic factors in carcinoma of the uterine cervix - a multivariable analysis of the effect of age, stage, histology and blood counts on survival","volume":"9","author":"Kapp","year":"1983","journal-title":"Int. J. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.010_bb0090","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/1097-0142(20010815)92:4<903::AID-CNCR1399>3.0.CO;2-2","article-title":"Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma - preliminary results","volume":"92","author":"Obermair","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.010_bb0095","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3109\/02841869509127188","article-title":"Prognostic value of pretreatment factors in patients with locally advanced-carcinoma of the uterine cervix treated by radiotherapy alone","volume":"34","author":"Pedersen","year":"1995","journal-title":"Acta Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0093-7754(01)90215-5","article-title":"The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience","volume":"28","author":"Thomas","year":"2001","journal-title":"Semin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0360-3016(94)00613-P","article-title":"Prognostic factors for local and distant recurrence in stage-I and stage-ii cervical-carcinoma","volume":"32","author":"Wernerwasik","year":"1995","journal-title":"Int. J. Radiat. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.ygyno.2017.05.010_bb0110","first-page":"309","article-title":"Prognostic factors in definitive radiotherapy of uterine cervical cancer","volume":"24","author":"Yalman","year":"2003","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2004.04.008","article-title":"Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a gynecologic oncology group study","volume":"94","author":"Winter","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"3 Suppl 1","key":"10.1016\/j.ygyno.2017.05.010_bb0120","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.ygyno.2005.07.079","article-title":"Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report","volume":"99","author":"Fuso","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.010_bb0125","article-title":"The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone","volume":"234","author":"Grigiene","year":"2007","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0130","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.ijrobp.2008.09.050","article-title":"Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer","volume":"74","author":"Mayr","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3802\/jgo.2015.26.1.12","article-title":"Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort","volume":"26","author":"Endo","year":"2015","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5468\/ogs.2014.57.1.28","article-title":"Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer","volume":"57","author":"Shin","year":"2014","journal-title":"Obstet. Gynecol. Sci."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00432-008-0430-2","article-title":"Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma","volume":"135","author":"Metindir","year":"2009","journal-title":"J. Cancer Res. Clin."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0150","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ygyno.2013.08.032","article-title":"Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas","volume":"131","author":"Njolstad","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2017.05.010_bb0155","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.7314\/APJCP.2012.13.7.3187","article-title":"Presence of anemia and poor prognostic factors in patients with endometrial carcinoma","volume":"13","author":"Wilairat","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0160","first-page":"837","article-title":"Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer","volume":"23","author":"Munstedt","year":"2003","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0165","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2005-01-0160","article-title":"Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia","volume":"106","author":"Maccio","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.010_bb0170","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO;2-U","article-title":"The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients","volume":"83","author":"Obermair","year":"1998","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2017.05.010_bb0175","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/01.IGC.0000436089.03581.6b","article-title":"The impact of perioperative packed red blood cell transfusion on survival in epithelial ovarian cancer","volume":"23","author":"Warner","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2017.05.010_bb0180","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1008365716693","article-title":"Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg\/m(2)","volume":"11","author":"Safra","year":"2000","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.010_bb0185","article-title":"Prognostic impact of hemoglobin levels before and during carboplatin\/taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer","volume":"15","author":"Eichbaum","year":"2009","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000030136","article-title":"Tumor anemia and thrombocytosis in patients with vulvar cancer","volume":"21","author":"Hefler","year":"2000","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ygyno.2017.05.010_bb0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/annonc\/mdq284","article-title":"Anemia in cancer","volume":"21","author":"Dicato","year":"2010","journal-title":"Ann. Oncol."},{"issue":"19","key":"10.1016\/j.ygyno.2017.05.010_bb0200","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jnci\/91.19.1616","article-title":"Chemotherapy-induced anemia in adults: incidence and treatment","volume":"91","author":"Groopman","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.ygyno.2017.05.010_bb0205","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/IGC.0b013e318229266a","article-title":"Does severe anemia caused by dose-dense paclitaxel-carboplatin combination therapy have an effect on the survival of patients with epithelial ovarian cancer? Retrospective analysis of the Japanese gynecologic oncology group 3016 trial","volume":"21","author":"Kumagai","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/gyno.2001.6185","article-title":"Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer","volume":"81","author":"Hensley","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1054\/bjoc.1999.0883","article-title":"Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy","volume":"82","author":"Barrett-Lee","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.010_bb0220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s004320000215","article-title":"Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice","volume":"127","author":"St\u00fcben","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.010_bb0225","series-title":"Biological predictors of cervical cancer response to radiation therapy","year":"2012"},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0360-3016(02)02896-1","article-title":"Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy","volume":"54","author":"Kapp","year":"2002","journal-title":"Int. J. Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2017.05.010_bb0235","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/0360-3016(86)90146-X","article-title":"The significance of anemia in clinical radiation therapy","volume":"12","author":"Bush","year":"1986","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0240","doi-asserted-by":"crossref","first-page":"628","DOI":"10.6004\/jnccn.2012.0064","article-title":"Cancer- and chemotherapy-induced anemia","volume":"10","author":"Rodgers","year":"2012","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2017.05.010_bb0245","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.9185","article-title":"Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage","author":"Carson","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0250","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000542-199603000-00032","article-title":"Practice guidelines for blood component therapy - a report by the American Society of Anesthesiologists Task Force on blood component therapy","volume":"84","author":"Stehling","year":"1996","journal-title":"Anesthesiology"},{"issue":"13","key":"10.1016\/j.ygyno.2017.05.010_bb0255","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199904013401322","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care (vol 340, pg 409, 1999)","volume":"340","author":"Hebert","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ygyno.2017.05.010_bb0260","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/jama.2010.1446","article-title":"Transfusion requirements after cardiac surgery the TRACS randomized controlled trial","volume":"304","author":"Hajjar","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.CCM.0000104112.34142.79","article-title":"The CRIT study: anemia and blood transfusion in the critically ill - current clinical practice in the United States","volume":"32","author":"Corwin","year":"2004","journal-title":"Crit. Care Med."},{"issue":"13","key":"10.1016\/j.ygyno.2017.05.010_bb0270","first-page":"1254","article-title":"Transfusion thresholds in high-risk patients after hip surgery REPLY","volume":"366","author":"Carson","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ygyno.2017.05.010_bb0275","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMoa1406617","article-title":"Lower versus higher hemoglobin threshold for transfusion in septic shock","volume":"371","author":"Holst","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2017.05.010_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002042.pub3","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","volume":"4","author":"Carson","year":"2012","journal-title":"Cochrane Db. Syst. Rev."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/ALN.0000000000000511","article-title":"Transfusion requirements in surgical oncology patients a prospective, randomized controlled trial","volume":"122","author":"de Almeida","year":"2015","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0290","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ygyno.2013.10.019","article-title":"Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients","volume":"132","author":"Boone","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1995.1266","article-title":"A survey of blood-transfusion practices of gynecologic oncologists","volume":"59","author":"Price","year":"1995","journal-title":"Gynecol. Oncol."},{"issue":"10061","key":"10.1016\/j.ygyno.2017.05.010_bb0300","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/S0140-6736(15)01313-6","article-title":"Transfusion reactions: prevention, diagnosis, and treatment","volume":"388","author":"Delaney","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ygyno.2017.05.010_bb0305","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.0041-1132.2004.04347.x","article-title":"Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel","volume":"44","author":"Kleinman","year":"2004","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.010_bb0310","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1537-2995.2010.02583.x","article-title":"Duration of red blood cell storage and survival of transfused patients (CME)","volume":"50","author":"Edgren","year":"2010","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.ygyno.2017.05.010_bb0315","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1111\/trf.12454","article-title":"How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention","volume":"53","author":"Andrzejewski","year":"2013","journal-title":"Transfusion"},{"issue":"7799","key":"10.1016\/j.ygyno.2017.05.010_bb0320","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(73)90164-5","article-title":"Immunological reactivity of transplant recipients","volume":"1","author":"Opelz","year":"1973","journal-title":"Lancet"},{"issue":"8242","key":"10.1016\/j.ygyno.2017.05.010_bb0325","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(81)90673-5","article-title":"Red-blood-cells for cancer-patients","volume":"2","author":"Gantt","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0330","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/bja\/aet068","article-title":"Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions","volume":"110","author":"Cata","year":"2013","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0335","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jss.2010.05.059","article-title":"Perioperative blood transfusions promote pancreas cancer progression","volume":"166","author":"Benson","year":"2011","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0340","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/SLA.0b013e31825b35d5","article-title":"Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery a systematic review and meta-analysis","volume":"256","author":"Acheson","year":"2012","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0345","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-3148.2011.01122.x","article-title":"The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer","volume":"22","author":"De Oliveira","year":"2012","journal-title":"Transfus. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0350","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0955-3886(96)00077-X","article-title":"The influence of peri-operative blood transfusion during radical hysterectomy on the prognosis of uterine cervical cancer","volume":"18","author":"Azuma","year":"1997","journal-title":"Transfus. Sci."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0355","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0029-7844(94)00398-W","article-title":"Does perioperative blood-transfusion affect survival in patients with cervical-cancer treated with radical hysterectomy","volume":"85","author":"Monk","year":"1995","journal-title":"Obstet. Gynecol."},{"issue":"19","key":"10.1016\/j.ygyno.2017.05.010_bb0360","first-page":"2045","article-title":"Health care-associated infection after red blood cell transfusion: a systematic review and metaanalysis (vol 311, pg 1317, 2014)","volume":"312","author":"Rohde","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0365","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jamcollsurg.2008.11.019","article-title":"Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients","volume":"208","author":"Bernard","year":"2009","journal-title":"J. Am. Coll. Surg."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0370","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2005.06.017","article-title":"Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival","volume":"99","author":"Abu-Rustum","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0375","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hoc.2016.01.005","article-title":"Pathogen inactivation technologies the advent of pathogen-reduced blood components to reduce blood safety risk","volume":"30","author":"Devine","year":"2016","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0380","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hoc.2016.01.005","article-title":"Pathogen inactivation technologies: the advent of pathogen-reduced blood components to reduce blood safety risk","volume":"30","author":"Devine","year":"2016","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0385","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/trf.13271","article-title":"Inactivation of Zika virus in plasma with amotosalen and ultraviolet a illumination","volume":"56","author":"Aubry","year":"2016","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.010_bb0390","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/vox.12287","article-title":"A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment","volume":"109","author":"Knutson","year":"2015","journal-title":"Vox Sang."},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.010_bb0395","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1537-2995.2008.01643.x","article-title":"A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment","volume":"48","author":"Osselaer","year":"2008","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.ygyno.2017.05.010_bb0400","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/trf.13259","article-title":"Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation","volume":"55","author":"Kleinman","year":"2015","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0405","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ygyno.2013.09.028","article-title":"Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy","volume":"131","author":"Athibovonsuk","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0410","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ygyno.2009.12.004","article-title":"Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy","volume":"116","author":"Dangsuwan","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0415","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ygyno.2006.11.014","article-title":"Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy","volume":"105","author":"Kim","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2017.05.010_bb0420","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2006.10.4620","article-title":"Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alfa administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia","volume":"26","author":"Bastit","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"11A","key":"10.1016\/j.ygyno.2017.05.010_bb0425","first-page":"69","article-title":"Contibution of anemia to fatigue in the cancer patient","volume":"14","author":"Sabbatini","year":"2000","journal-title":"Oncology (Williston Park)"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2017.05.010_bb0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1634\/theoncologist.5-suppl_2-19","article-title":"The relationship between anemia and quality of life in cancer patients","volume":"5","author":"Sabbatini","year":"2000","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0435","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood-2007-08-109488","article-title":"Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology\/American Society of Clinical Oncology clinical practice guideline update","volume":"111","author":"Rizzo","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ygyno.2017.05.010_bb0440","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.2004.08.119","article-title":"Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial","volume":"22","author":"Auerbach","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0445","first-page":"129","article-title":"Administration of recombinant human erythropoietin in patients with gynecological cancer before radical surgery","volume":"32","author":"Dousias","year":"2005","journal-title":"Clin. Exp. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2017.05.010_bb0450","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6603004","article-title":"Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial","volume":"94","author":"Wilkinson","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0455","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF02821936","article-title":"Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy","volume":"15","author":"Huinink","year":"1998","journal-title":"Med. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2017.05.010_bb0460","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.2015.63.5649","article-title":"A randomized, open-label, multicenter, phase III study of epoetin alfa versus best standard of care in anemic patients with metastatic breast cancer receiving standard chemotherapy","volume":"34","author":"Leyland-Jones","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0465","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0030-1255448","article-title":"Thrombotic complications of erythropoiesis-stimulating agents","volume":"36","author":"Lippi","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"issue":"20","key":"10.1016\/j.ygyno.2017.05.010_bb0470","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-10-2577","article-title":"The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression","volume":"17","author":"Hedley","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0475","doi-asserted-by":"crossref","first-page":"659","DOI":"10.6004\/jnccn.2012.0065","article-title":"Update on safety of ESAs in cancer-induced anemia","volume":"10","author":"Glaspy","year":"2012","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0480","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2004.07.009","article-title":"Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a southwest oncology group study","volume":"95","author":"Lavey","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0485","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ygyno.2007.10.011","article-title":"Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0g\/dL with erythropoietin vs above 10.0 g\/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer","volume":"108","author":"Thomas","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"28","key":"10.1016\/j.ygyno.2017.05.010_bb0490","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1200\/JCO.2010.30.4899","article-title":"Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study","volume":"29","author":"Blohmer","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0495","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1213\/ANE.0000000000001609","article-title":"Acute normovolemic hemodilution reduces allogeneic red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis of randomized trials","volume":"124","author":"Barile","year":"2017","journal-title":"Anesth. Analg."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.010_bb0500","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archsurg.1993.01420140083013","article-title":"Intraoperative autotransfusion in hepatic resection for malignancy. Is it safe?","volume":"128","author":"Zulim","year":"1993","journal-title":"Arch. Surg."},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.010_bb0505","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0002-9378(99)70369-8","article-title":"The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer","volume":"181","author":"Mirhashemi","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0510","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0029-7844(95)00183-R","article-title":"Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix","volume":"86","author":"Connor","year":"1995","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0515","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00404-012-2351-1","article-title":"Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: long-term follow-up of a prospective trial","volume":"286","author":"Engle","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.010_bb0520","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/bja\/aet068","article-title":"Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions","volume":"110","author":"Cata","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ygyno.2017.05.010_bb0525","doi-asserted-by":"crossref","first-page":"d5701","DOI":"10.1136\/bmj.d5701","article-title":"Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial","volume":"343","author":"Crescenti","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.010_bb0530","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/aogs.12333","article-title":"Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study","volume":"93","author":"Lundin","year":"2014","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.010_bb0535","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tmrv.2016.05.012","article-title":"Patient blood management bundles to facilitate implementation","volume":"31","author":"Meybohm","year":"2017","journal-title":"Transfus. Med. Rev."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0540","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.010_bb0545","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-135-3-200108070-00007","article-title":"Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials","volume":"135","author":"Wilkes","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2017.05.010_bb0550","doi-asserted-by":"crossref","first-page":"14750","DOI":"10.1038\/ncomms14750","article-title":"An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells","volume":"8","author":"Trakarnsanga","year":"2017","journal-title":"Nat. Commun."}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2017.11.030","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817308491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817308491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T14:24:26Z","timestamp":1535811866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817308491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0090825817308491"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.010","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ygyno.2017.11.030","asserted-by":"object"}]},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications for and complications of transfusion and the management of gynecologic malignancies","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}